Risk Factors Regarding Portal Vein Thrombosis in Chronic Liver Disease

1. Manzano-Robleda MC, Barranco-Fragoso B, Uribe M et al, Portal vein thrombosis: What is new?, Annals of Hepatology, January-February, 2015;14(1):20-27. https://pubmed.ncbi.nlm.nih.gov/25536638/, Accessed: on 06.05.2020.10.1016/S1665-2681(19)30797-5Search in Google Scholar

2. Gîrleanu I, Trifan A, Stanciu C, et al. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture, World J Gastroenterol, October 2018;24(39):4419-4427, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196341/, Accessed on 06.05.2020.10.3748/wjg.v24.i39.4419Search in Google Scholar

3. Hoekstra J, Janssen HL. Vascular liver disorders (II): portal vein thrombosis, Neth J Med. 2009;67(2):46-53, https://pubmed.ncbi.nlm.nih.gov/19299846/, Accessed on 06.05.2020.Search in Google Scholar

4. Vecerzan L, Boicean A, Cipăian CR, et al. The correlation between conventional coagulation tests and the study of thrombin generation in patients with liver cirrhosis, Acta Medica Transilvanica. 2019:24(2):31-33.Search in Google Scholar

5. Chen H, Trilok G, Wang F, et al. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors, Indian J Med Res. 2014 Feb; 139(2):260-266.Search in Google Scholar

6. Ushitora Y, Tashiro H, Takahashi S, et al. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg. 2011;28:9-14. [PubMed: 21293126].10.1159/000321886Search in Google Scholar

7. Yue-Meng W, Yu-Hua Li, Hua-Mei Wu, et al. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes, Clinical and Applied Thrombosis/Hemostasis. 2018;24(3):462-470.10.1177/1076029616689593Search in Google Scholar

8. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. Journal of hepatology. 1995;22(2):165-72.10.1016/0168-8278(95)80424-2Search in Google Scholar

9. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367:1075-9.10.1016/S0140-6736(06)68474-2Search in Google Scholar

10. Levi M, Keller TT, van Gorp E, et al. Infection and inflammation and the coagulation system. Cardiovasc Res. 2003;60:26-39.10.1016/S0008-6363(02)00857-XSearch in Google Scholar

11. Basili S, Carnevale R, Nocella C, et al. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis, Hepatology Communications. 2019;3(4).10.1002/hep4.1317Search in Google Scholar

12. Jong MK, Choon HDK, Jae-Won J, et al. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion, World Journal of Surgical Oncology. 2013;11:92.10.1186/1477-7819-11-92Search in Google Scholar

13. Hunt AH WB. Thrombosis of the portal vein in cirrhosis hepatis. Lancet. 1954;263(6806):281-4.10.1016/S0140-6736(54)91032-6Search in Google Scholar

14. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clinical laboratory. 2007;53(9-12):583-9.Search in Google Scholar

15. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. Journal of Hepatology. 2009;51(4):682-9.10.1016/j.jhep.2009.03.01319464747Search in Google Scholar